Gordon Brooks active positions
| Companies | Position | Start | End |
|---|---|---|---|
| ARMO BIOSCIENCES INC | Director/Board Member | 2018-06-20 | - |
| DERMIRA, INC. | Director/Board Member | 2020-02-19 | - |
| SIGILON THERAPEUTICS, INC. | Director/Board Member | 2023-08-10 | - |
Career history of Gordon Brooks
Statistics
International
| United States | 4 |
Operational
| Director/Board Member | 3 |
Sectoral
| Health Technology | 4 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 1 |
|---|---|
| SIGILON THERAPEUTICS, INC. | Health Technology |
| Private companies | 2 |
|---|---|
ARMO BioSciences, Inc.
 ARMO BioSciences, Inc. Pharmaceuticals: MajorHealth Technology ARMO BioSciences, Inc. develops immunotherapy for the treatment of cancer, cardiovascular diseases, fibrosis, and inflammation. Its lead product candidate is AM0010 (pegilodecaki). The company was founded by Peter Van Vlasselaer, Martin Oft, and John B. Mumm on June 23, 2010 and is headquartered in Redwood, CA. | Health Technology |
Dermira, Inc.
 Dermira, Inc. Pharmaceuticals: MajorHealth Technology Dermira, Inc. is a biopharmaceutical company. It engages in the provision of therapies for chronic skin conditions. The company was founded by Thomas G. Wiggans, Eugene Andrew Bauer, Luis C. Peña, and Christopher M. Griffith on August 18, 2010 and is headquartered in Indianapolis, IN. | Health Technology |
- Stock Market
- Insiders
- Gordon Brooks
- Experience
